Armen Vidian Overview
- Firm
- Recode Health Ve...
- Primary Position
-
Co-Founder & Man...
- Primary Industry
-
Healthcare
- Active Board Seats
-
2
- Med. Deal Size
-
- Med. Valuation
-
Armen Vidian General Information
Biography
Mr. Armen Vidian is a Co-Founder & serves as Managing Partner at Recode Health Ventures. He also serves as an Advisor at HealthMode. He served as a Board Member at Model Medicines. He has nearly 30 years of experience as an engineer, entrepreneur, and investor in technology and healthcare. He started his career creating first-in-class products in medical technology. He then co-founded BlueTalon [acquired by MSFT], initially focusing on the interface between data federation and clinical trials. His experience in healthcare and technology has focused his interests on the application of generative AI, robotics, AR/VR, and brain-computer interfaces in healthcare and the life sciences. After BlueTalon, He was an Partner at DCVC, the first venture capital firm with an AI-centric thesis. At DCVC, he played a leadership role in the investment of the first companies applying AI to healthcare and the life sciences. Some of his board responsibilities included: Board Chairman at Caption Health [acquired by GE HealthCare]; and Board Director at Proprio. In addition to these responsibilities, he led or co-led investments in AbCellera [NASD: ABCL], Recursion [NASD: RXRX], and Healthmode [NASD: MNMD]. He holds an S.B. in Mechanical Engineering from the Massachusetts Institute of Technology (MIT) and an M.S. in Management Science and Engineering from Stanford University. His history with data and healthcare goes back to college, during which he co-authored a paper on the use of autoregressive moving average analysis (ARMA) to characterize baroreflex gain in a 1996 issue of the American Journal of Physiology: Heart and Circulation. Originally from Racine, Wisconsin, his perspective as a venture capitalist is influenced as a first-generation college graduate.
Contact Information
Address
- 95 3rd Street
- 2nd Floor
- San Francisco, CA 94103
- United States
Armen Vidian Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Recode Health Ventures | Investor | Co-Founder & Managing Partner | San Francisco, CA | Venture Capital |
Armen Vidian Board Seats (2)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Model Medicines | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | La Jolla, CA | |
Vium | Discovery Tools (Healthcare) | Acquired/Merged (Operating Subsidiary) | Formerly VC-backed | San Mateo, CA |
Armen Vidian Lead Partner on Deals (5)
Armen Vidian has been the lead partner on 5 deals. Their latest deal was with Evonetix, a biotechnology company. The deal was made for on 07-Feb-2023.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Evonetix | 07-Feb-2023 | Later Stage VC (Series B) | Completed | Biotechnology | Cambridge, United Kingdom | |
Caption Care | 15-Jul-2020 | Completed | Other Healthcare Technology Systems | San Mateo, CA | ||
Proprio | 11-Jun-2020 | Completed | Surgical Devices | Seattle, WA | ||
Strateos | 03-Jun-2019 | Later Stage VC (Series A) | Completed | Laboratory Services (Healthcare) | Menlo Park, CA | |
Caption Care | 09-Dec-2016 | Early Stage VC (Series A) | Completed | Other Healthcare Technology Systems | San Mateo, CA |
Armen Vidian Network (83)
Board Members (38)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Peter Hébert | Vium | Lux Capital | San Mateo, CA | |
Samuel Chun | Cofactor Genomics | Self | Saint Louis, MO | |
Strateos | Self | Menlo Park, CA | ||
Model Medicines | Self | La Jolla, CA | ||
Strateos | Lux Capital | Menlo Park, CA |
Portfolio Executives (38)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Colin McCracken | Evonetix | Chief Executive Officer & Board Member | 07-Feb-2023 | Cambridge, United Kingdom |
Andrew Diston | Evonetix | Chief Executive Officer & Board Member | 07-Feb-2023 | Cambridge, United Kingdom |
Evonetix | Co-Founder, Chief Technology Officer and Board Member | 07-Feb-2023 | Cambridge, United Kingdom | |
Evonetix | Chief Operations Officer | 07-Feb-2023 | Cambridge, United Kingdom | |
Evonetix | Chief Executive Officer & Board Member | 07-Feb-2023 | Cambridge, United Kingdom |
Fund Team Members (7)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Jason Pontin | DCVC | DCVC Opportunity Fund II | Palo Alto, CA |
Alan Cohen | DCVC | DCVC Opportunity Fund II | Palo Alto, CA |
DCVC | Palo Alto, CA | ||
DCVC | Palo Alto, CA | ||
DCVC | Palo Alto, CA |
Armen Vidian Affiliated Funds (2)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
DCVC Opportunity Fund II | DCVC | Venture Capital - Later Stage | Closed | 2017 | ||||
DCVC Opportunity Fund | DCVC | Venture Capital - Later Stage | Closed | 2015 |
Armen Vidian Advisory Roles (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
HealthMode | Company | Advisor | San Francisco, CA | Other Healthcare Technology Systems |
Armen Vidian FAQs
-
Who is Armen Vidian?
Mr. Armen Vidian is a Co-Founder & serves as Managing Partner at Recode Health Ventures.
-
How much does Armen Vidian typically invest?
Armen Vidian's median deal size is
. -
What is Armen Vidian’s main position?
Armen Vidian’s primary position is Co-Founder & Managing Partner.
-
What are the contact details for Armen Vidian?
Armen Vidian’s email address is ar
and his phone number is +1 (949) . -
How many active board seats does Armen Vidian hold?
Armen Vidian holds 2 board seats including Model Medicines and Vium.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »